Related Experiment Video
Updated: Aug 10, 2025

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
Published on: March 18, 2022
Subchondral Bone Cyst Development in Osteoarthritis: From Pathophysiology to Bone Microarchitecture Changes and
Angelos Kaspiris1, Argyris C Hadjimichael2, Ioanna Lianou3
1Laboratory of Molecular Pharmacology, Department of Pharmacy, School of Health Sciences, University of Patras, 26504 Patras, Greece.
Subchondral bone cysts (SBCs) in osteoarthritis develop due to mechanical stress and inflammation. Treatments like microspheres and chondrocytes can hinder SBC expansion and slow osteoarthritis progression.
Area of Science:
- Orthopedics
- Rheumatology
- Cell Biology
Background:
- Osteoarthritis (OA) is a degenerative joint disease impacting middle-aged and elderly individuals, primarily affecting weight-bearing joints.
- Common OA manifestations include cartilage defects, joint space narrowing, osteophytes, bone sclerosis, and subchondral bone cysts (SBCs).
- SBCs are associated with OA progression, clinical symptoms, and potential complications after joint replacement surgery.
Purpose of the Study:
- To investigate the pathophysiology behind subchondral bone cyst (SBC) development in osteoarthritis (OA).
- To explore the relationship between SBCs and OA disease progression, clinical symptom severity, and postoperative outcomes.
- To assess the risk of complications following joint replacement if SBCs remain untreated.
Main Methods:
- A comprehensive literature review was performed using PubMed to gather evidence on SBC formation and its implications in OA.
- The review evaluated existing theories on SBC pathogenesis, including matrix metalloproteinases (MMPs) secretion, angiogenesis, and bone turnover.
- The study assessed the impact of various therapeutic interventions on SBCs and OA progression.
Main Results:
- Several theories explain SBC formation, involving MMPs secretion, angiogenesis, and heightened bone turnover as responses to mechanical stress and tissue injury.
- Novel therapeutic approaches, including celecoxib-coated microspheres, IGF-1 administration, and activated chondrocytes post-debridement, show promise in managing SBCs.
- These treatments appear to inhibit SBC expansion and mitigate OA progression.
Conclusions:
- Subchondral bone cysts (SBCs) are a significant feature of osteoarthritis, linked to disease severity and treatment outcomes.
- Understanding the pathophysiology of SBCs is crucial for developing effective management strategies.
- Emerging therapeutics demonstrate potential in halting SBC growth and slowing the advancement of osteoarthritis, improving patient prognosis.
More Related Videos
Related Concept Videos
Bone Formation by Endochondral Ossification
Growth of Cartilage and Bone Tissue
Bone Remodeling
Osteoclasts in Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Fractures: Bone Repair
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...

